October 17 – 19 2017 | Boston, MA

Hilton Boston/Woburn

Enhance the Application of Predictive, Monitoring & Resistance Biomarkers to Achieve Precise Drug Development

Taking place at World CDx, Clinical Biomarkers Summit will unite large pharma and biotech drug developers to help them more granularly and robustly develop biomarker signatures through the discovery, development and clinical validation of predictive, monitoring and resistance biomarkers. Gain insight into novel signatures for next generation therapeutics and learn how to best validate and implement your biomarker assay in the clinical setting.

Join biomarker, translational and clinical specialists seeking more accurate and detailed responder profiles in order to truly define your target patients and streamline the clinical progress of more safe, effective and commercially successful precision medicine drug candidates.

 

Brochure button clinical

 

"Great meeting with a small crowd and high quality talks."
-Biosciences Senior Clinical Scientist, Cleave Biosciences

Media Partner